Featured

[Special Report] Trademark filing and litigation trends 2024: Insights and opportunities

Robert Reading

Director, Corporate Strategy, Content at Clarivate

Biopharma
What a string of semaglutide biosimilars could mean for Mainland China
Academia and Government
Introducing the Clarivate Academic AI Platform
Life Sciences and Healthcare
January 4, 2017
Academia and Government
December 28, 2016
Academia and Government
December 28, 2016
Academia and Government
December 14, 2016
Intellectual Property
December 14, 2016
Academia and Government
December 14, 2016
Life Sciences and Healthcare
December 14, 2016
Life Sciences and Healthcare
December 14, 2016
Academia and Government
December 13, 2016